Calvert Holdings provides vision, resources, and business leadership for all of the companies it develops and acquires. Life sciences are a core competency, but not all our business endeavors are within that field. Click the links to explore our companies, or contact us for more information.
Contact Calvert Holdings

home-page-full

line-break

our-services-buttonWe are experienced in virtually all classes of compounds and offer capabilities in the performance of studies to support the safety evaluation of drugs, biologics, proteins, peptides, gene therapy compounds, monoclonal antibodies, and other chemicals, as well as devices from not only the discovery phase, but through the preclinical phase to IND submissions, including the first-into-man studies. Calvert also performs studies to support NDA submissions.